MABVAX THERAPEUTICS HOLDINGS, INC.

Profile

Company Names

MABVAX THERAPEUTICS HOLDINGS, INC.
TELIK INC

Addresses

11535 SORRENTO VALLEY RD., SUITE 400, SAN DIEGO, CA 92121

11588 SORRENTO VALLEY ROAD, SUITE 20, SAN DIEGO, CA 92121

2100 GENG ROAD, SUITE 102, PALO ALTO, CA 94303

Phone Numbers

858-259-9405
8582599405
6508457700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$24,960,751.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-04-30 
$830,000.00 
$860,000.00 
$30,000.00 
Equity 
4
2018-02-02 
$2,750,000.00 
$2,750,000.00 
$0.00 
Equity 
3
2015-03-31 
$11,614,501.00 
$15,000,000.00 
$3,385,499.00 
Equity 
2
2014-07-08 
$5,185,000.00 
$5,185,000.00 
$0.00 
Equity 
1
2014-05-12 
$4,581,250.00 
$4,581,250.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIM 
J. 
ANTONOPOULOS 
DIRECTOR
TELIK INC   |  MABVAX THERAPEUTICS INC
EDWARD 
W. 
CANTRALL 
DIRECTOR
TELIK INC
KENNETH 
 
COHEN 
DIRECTOR
STEADYSLEEP RX CO.   |  MABVAX THERAPEUTICS HOLDINGS, INC.
KENNETH 
M. 
COHEN 
DIRECTOR
ADAMIS PHARMACEUTICALS CORP   |  TELIK INC   |  MABVAX THERAPEUTICS INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.
JEFFREY 
 
EISENBERG 
DIRECTOR
CALISTOGA HOTEL GROUP, LP   |  EP HAMMS, LLC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  XENETIC BIOSCIENCES, INC.
JEFFREY 
F. 
EISENBERG 
DIRECTOR
MABVAX THERAPEUTICS HOLDINGS, INC.
STEVEN 
R. 
GOLDRING 
DIRECTOR
TELIK INC
J. 
DAVID 
HANSEN 
EXECUTIVE OFFICER, DIRECTOR
MABVAX THERAPEUTICS INC   |  TELIK INC
J. DAVID 
 
HANSEN 
EXECUTIVE OFFICER, DIRECTOR
MABVAX THERAPEUTICS HOLDINGS, INC.
GREGORY 
 
HANSON 
EXECUTIVE OFFICER, DIRECTOR
MABVAX THERAPEUTICS HOLDINGS, INC.   |  MN-NY MEDICAL VENTURES, LLC
GREGORY 
P. 
HANSON 
EXECUTIVE OFFICER
TELIK INC   |  MABVAX THERAPEUTICS INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.
ROBERT 
 
HOFFMAN 
DIRECTOR
PRINCETON OPPORTUNITY PARTNERS, LP   |  COMBIMATRIX CORP   |  SG HOLDINGS, LLC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  SHENANDOAH GROWERS, INC.   |  ANAPTYSBIO INC   |  KINTARA THERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC./NV   |  FIBROBIOLOGICS, INC.
WILLIAM 
P. 
KAPLAN 
EXECUTIVE OFFICER
TELIK INC
PHILIP 
 
LIVINGSTON 
DIRECTOR
MABVAX THERAPEUTICS INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.
PHILIP 
O. 
LIVINGSTON 
EXECUTIVE OFFICER, DIRECTOR
MABVAX THERAPEUTICS INC   |  TELIK INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.
PAUL 
 
MAFFUID 
EXECUTIVE OFFICER
MABVAX THERAPEUTICS HOLDINGS, INC.
PAUL 
W. 
MAFFUID 
EXECUTIVE OFFICER
MABVAX THERAPEUTICS HOLDINGS, INC.
PAUL 
 
MAIER 
DIRECTOR
SEQUENOM INC   |  PURE BIOSCIENCE, INC.   |  INTERNATIONAL STEM CELL CORP   |  TELIK INC   |  MABVAX THERAPEUTICS INC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  BIOLOGICAL DYNAMICS INC   |  CONVERGEONE HOLDINGS, INC.
PAUL 
V. 
MAIER 
DIRECTOR
HANA BIOSCIENCES INC   |  PURE BIOSCIENCE   |  TALON THERAPEUTICS, INC.   |  APRICUS BIOSCIENCES, INC.   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  RITTER PHARMACEUTICALS INC
RICHARD 
B. 
NEWMAN 
DIRECTOR
TELIK INC
JEFFREY 
 
RAVETCH 
DIRECTOR
MABVAX THERAPEUTICS HOLDINGS, INC.
JEFFREY 
V. 
RAVETCH 
DIRECTOR
TELIK INC   |  MABVAX THERAPEUTICS INC
PAUL 
 
RESNICK 
EXECUTIVE OFFICER
MABVAX THERAPEUTICS HOLDINGS, INC.   |  CELLULAR LOGISTICS, INC.
STEVEN 
R. 
SCHOW 
EXECUTIVE OFFICER
TELIK INC
THOMAS 
 
VARRANO 
DIRECTOR
MABVAX THERAPEUTICS HOLDINGS, INC.
THOMAS 
 
VARVARO 
DIRECTOR
CHROMADEX CORP.   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  LIQUID SCIENCE HOLDINGS, LLC
THOMAS 
C. 
VARVARO 
DIRECTOR
CHROMADEX CORP.   |  MABVAX THERAPEUTICS HOLDINGS, INC.
WENDY 
K. 
WEE 
EXECUTIVE OFFICER
TELIK INC
MICHAEL 
M. 
WICK 
DIRECTOR, EXECUTIVE OFFICER
TELIK INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-05-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-04-30 
2018-02-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-02-02 
2015-04-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-31 
2014-07-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-07-08 
2014-05-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2014-05-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LAIDLAW + COMPANY, LTD.
119037
AXIOM CAPITAL MANAGEMENT, INC.
26580
PALLADIUM CAPITAL ADVISORS, LLC
129400
AXIOM CAPITAL MANAGEMENT, INC.
26580